Literature DB >> 19057932

A very large C-loop in EGF domain IV is characteristic of the P28 family of ookinete surface proteins.

Babita Sharma1, Rahul Dev Ambedkar, Ajay K Saxena.   

Abstract

The P28 family of proteins are 28 kDa proteins expressed on the surface of sexual stages--zygote, ookinete and young oocyst stages--of Plasmodium species when the parasite resides inside the mosquito midgut. Together with P25 proteins, P28 proteins protect the parasite from the harsh proteolytic environment prevailing inside the mosquito midgut. Vaccines against these proteins induce antibodies in vertebrate hosts that are capable of inhibiting parasite development in the mosquito midgut, thus preventing transmission of the parasite from the mosquito to another human host. These transmission-blocking vaccines are helpful in reducing the burden caused by malaria, which affects 300-600 million, and kills 1-3 million, people annually. The purpose of this study was to structurally characterise six members of the P28 family of ookinete surface proteins with the help of homology modelling, to compare these proteins in terms of transmission blocking and host parasite interactions, and to analyse phylogenetic relationships within the P28 family and with the P25 family. Our results indicate that all the members of the P28 family studied have four EGF domains arranged in triangular fashion with a very big C loop present in EGF domain IV, which could serve as a diagnostic feature of the P28 family as this loop is absent in the P25 family of ookinete surface proteins. The models of the P28 family of ookinete surface proteins obtained may help in understanding the biology of the parasite inside the mosquito midgut, and in designing transmission-blocking vaccines against malaria in the absence of experimentally determined structures of these important surface proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19057932     DOI: 10.1007/s00894-008-0392-y

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  33 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions.

Authors:  A M Tomas; G Margos; G Dimopoulos; L H van Lin; T F de Koning-Ward; R Sinha; P Lupetti; A L Beetsma; M C Rodriguez; M Karras; A Hager; J Mendoza; G A Butcher; F Kafatos; C J Janse; A P Waters; R E Sinden
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

3.  Multiple sequence alignment with the Clustal series of programs.

Authors:  Ramu Chenna; Hideaki Sugawara; Tadashi Koike; Rodrigo Lopez; Toby J Gibson; Desmond G Higgins; Julie D Thompson
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

4.  WHAT IF: a molecular modeling and drug design program.

Authors:  G Vriend
Journal:  J Mol Graph       Date:  1990-03

5.  A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines.

Authors:  P E Duffy; D C Kaslow
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

6.  Ookinete antigens of Plasmodium berghei: a light and electron-microscope immunogold study of expression of the 21 kDa determinant recognized by a transmission-blocking antibody.

Authors:  R E Sinden; L Winger; E H Carter; R H Hartley; N Tirawanchai; C S Davies; J Moore; J F Sluiters
Journal:  Proc R Soc Lond B Biol Sci       Date:  1987-05-22

7.  Two antigens on zygotes and ookinetes of Plasmodium yoelii and Plasmodium berghei that are distinct targets of transmission-blocking immunity.

Authors:  T Tsuboi; Y M Cao; Y Hitsumoto; T Yanagi; H Kanbara; M Torii
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

8.  Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates.

Authors:  T Tsuboi; D C Kaslow; M M Gozar; M Tachibana; Y M Cao; M Torii
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

9.  The global distribution of clinical episodes of Plasmodium falciparum malaria.

Authors:  Robert W Snow; Carlos A Guerra; Abdisalan M Noor; Hla Y Myint; Simon I Hay
Journal:  Nature       Date:  2005-03-10       Impact factor: 49.962

10.  Structure and expression of a post-transcriptionally regulated malaria gene encoding a surface protein from the sexual stages of Plasmodium berghei.

Authors:  M G Paton; G C Barker; H Matsuoka; J Ramesar; C J Janse; A P Waters; R E Sinden
Journal:  Mol Biochem Parasitol       Date:  1993-06       Impact factor: 1.759

View more
  2 in total

1.  The biology of sexual development of Plasmodium: the design and implementation of transmission-blocking strategies.

Authors:  Robert E Sinden; Richard Carter; Chris Drakeley; Didier Leroy
Journal:  Malar J       Date:  2012-03-16       Impact factor: 2.979

2.  Evolution of the Transmission-Blocking Vaccine Candidates Pvs28 and Pvs25 in Plasmodium vivax: Geographic Differentiation and Evidence of Positive Selection.

Authors:  Ricardo A Chaurio; M Andreína Pacheco; Omar E Cornejo; Ester Durrego; Craig E Stanley; Andreína I Castillo; Sócrates Herrera; Ananias A Escalante
Journal:  PLoS Negl Trop Dis       Date:  2016-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.